Developer docs
API playgroundTry for free, no card

Search company profiles

Wintac Ltd.

Full company profile

uuid0037evc

Namestring
Wintac Ltd.
Legal namestring
Wintac Ltd.
Company typeenum
Public
Founded yearint
1987
Descriptiontext

Wintac Ltd. is a Bengaluru, India-based pharmaceutical manufacturer that has operated since 1987 (operating under the Somerset Therapeutics Private Limited entity, CIN U85110KA1990PTC011166) and maintains an FDA-inspected sterile manufacturing facility with proven R&D capabilities in sterile injectables and ophthalmics. Its product portfolio spans large and small volume parenterals (vials from 1ml to 100ml and ampoules from 1ml to 10ml) covering therapeutic categories such as NSAIDs, calcium supplements, anti-emetics, analgesics, antimalarials, anesthetics, anti-infectives, antimuscarinics, diuretics, cardiovascular, antihistamines, and iron supplements, alongside an ophthalmic range including anti-glaucoma, anti-cholinergic, artificial tears, steroids, anti-infectives, anti-allergics, and decongestants. The company monetizes primarily through contract manufacturing services for multinational pharmaceutical clients — explicitly naming Sanofi-Aventis, Novartis, Bayer, and Alcon US as long-tenured customers — supplemented by in-house analytical services, dossier/CTD compilation, and formulation processing for the US market. Its facility has been approved by the US FDA and the French regulatory authority AFSSAPS, and the company operates a dedicated regulatory team supporting generic product development and global drug registration.

Short descriptiontext

Wintac Ltd. (operating as Somerset Therapeutics Private Limited) is a Bengaluru-based, FDA-inspected pharmaceutical contract manufacturer producing sterile injectable and ophthalmic products for global multinational clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBengaluru, India
HQ citystring
Bengaluru
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
sterile injectables manufacturing, ophthalmic pharmaceutical products, contract drug manufacturing, FDA-inspected cGMP facility, formulation development services
Industry3 codes
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Contract Manufacturing
No data
Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wintac Ltd. operates an FDA-inspected sterile manufacturing facility focused on contract manufacturing of sterile injectable and ophthalmic pharmaceutical products. The company provides formulation, development, and commercial-scale production services for global pharmaceutical clients, leveraging cGMP-compliant operations and regulatory expertise.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Sterile Injectable Contract Manufacturing
CategoryPharmaceutical Manufacturing Services
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers9 records
TypeRegional player
Description

India-based pharmaceutical manufacturer with ophthalmic and specialty product offerings serving emerging and regulated markets. Comparable on ophthalmic manufacturing capabilities and India-CDMO model.

TypeBroad incumbent
Description

Indian generic manufacturer with US FDA-approved injectable manufacturing and a broad product portfolio. Comparable on injectable manufacturing capabilities and regulated market supply, though much larger and more diversified.

TypeBroad incumbent
Description

Indian pharmaceutical manufacturer with a sterile injectables portfolio and US FDA-approved facilities. Comparable on injectable manufacturing and US market access, though diversified across multiple dosage forms and therapy areas.

TypeOthers
Description

Global leader in ophthalmic pharmaceuticals and a stated customer of Wintac. Included as an adjacent ecosystem participant — both a customer and a benchmark for the ophthalmic capabilities Wintac has built.

TypeBroad incumbent
Description

Major Indian pharma company with sterile injectable and ophthalmic manufacturing capabilities. Comparable product overlap (injectables + ophthalmics) and similar India-based regulated market footprint, though at far larger scale.

TypeDirect peer
Description

Indian pharma company with a focused sterile injectables (including ophthalmics) portfolio supplying the US market. Direct comparable on injectable focus, India manufacturing base, and US FDA-regulated supply model.

TypeRegional player
Description

India-based pharmaceutical manufacturer serving regulated markets with API and intermediate capabilities. Regionally and operationally comparable as another Indian pharma manufacturer serving global regulated customers.

TypeBroad incumbent
Description

Large Indian generic and injectable manufacturer with US FDA-approved sterile facilities serving regulated markets. Overlaps with Wintac on injectable manufacturing and US supply, but operates at materially greater scale and breadth.

TypeDirect peer
Description

India-based sterile injectable manufacturer and CDMO with US FDA-approved facilities supplying global pharma companies. Direct comparable on geography, manufacturing footprint, injectable focus, and customer profile.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wintac Ltd.

Pharmaceutical Contract Manufacturingwintaclimited.com

Wintac Ltd. (operating as Somerset Therapeutics Private Limited) is a Bengaluru-based, FDA-inspected pharmaceutical contract manufacturer producing sterile injectable and ophthalmic products for global multinational clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US.

What Wintac Ltd. does

Wintac Ltd. is a Bengaluru, India-based pharmaceutical manufacturer that has operated since 1987 (operating under the Somerset Therapeutics Private Limited entity, CIN U85110KA1990PTC011166) and maintains an FDA-inspected sterile manufacturing facility with proven R&D capabilities in sterile injectables and ophthalmics. Its product portfolio spans large and small volume parenterals (vials from 1ml to 100ml and ampoules from 1ml to 10ml) covering therapeutic categories such as NSAIDs, calcium supplements, anti-emetics, analgesics, antimalarials, anesthetics, anti-infectives, antimuscarinics, diuretics, cardiovascular, antihistamines, and iron supplements, alongside an ophthalmic range including anti-glaucoma, anti-cholinergic, artificial tears, steroids, anti-infectives, anti-allergics, and decongestants. The company monetizes primarily through contract manufacturing services for multinational pharmaceutical clients — explicitly naming Sanofi-Aventis, Novartis, Bayer, and Alcon US as long-tenured customers — supplemented by in-house analytical services, dossier/CTD compilation, and formulation processing for the US market. Its facility has been approved by the US FDA and the French regulatory authority AFSSAPS, and the company operates a dedicated regulatory team supporting generic product development and global drug registration.

Wintac Ltd. firmographics

Firmographics
Name
Wintac Ltd.
Legal name
Wintac Ltd.
Website
https://wintaclimited.com
Company type
Public
Founded year
1987
Operating status
Operating
Headcount range
101–250 employees
Short description
Wintac Ltd. (operating as Somerset Therapeutics Private Limited) is a Bengaluru-based, FDA-inspected pharmaceutical contract manufacturer producing sterile injectable and ophthalmic products for global multinational clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US.
Ownership category
akta.pro rank

Wintac Ltd. industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Sterile injectables manufacturing
  • Ophthalmic pharmaceutical products
  • Contract drug manufacturing
  • FDA-inspected cGMP facility
  • Formulation development services

Where Wintac Ltd. is headquartered

Location

Headquarters

HQ city
Bengaluru
HQ country
India
HQ region
Asia

Markets served

Wintac Ltd. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Wintac Ltd. product offering

Product offering

Core offering

Wintac Ltd. operates an FDA-inspected sterile manufacturing facility focused on contract manufacturing of sterile injectable and ophthalmic pharmaceutical products. The company provides formulation, development, and commercial-scale production services for global pharmaceutical clients, leveraging cGMP-compliant operations and regulatory expertise.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sterile Injectable Contract Manufacturing

Companies that use Wintac Ltd.

Customer profile

Ideal customer profiles1 record

Wintac Ltd. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Wintac Ltd. partnerships and signals

Strategic signal

Scale indicators1 record

Wintac Ltd. competitors and assessment

Company assessment

Regional players

  • Ajanta Pharma: India-based pharmaceutical manufacturer with ophthalmic and specialty product offerings serving emerging and regulated markets. Comparable on ophthalmic manufacturing capabilities and India-CDMO model.
  • Hikal Ltd. India-based pharmaceutical manufacturer serving regulated markets with API and intermediate capabilities. Regionally and operationally comparable as another Indian pharma manufacturer serving global regulated customers.

Broad incumbents

  • Lupin: Indian generic manufacturer with US FDA-approved injectable manufacturing and a broad product portfolio. Comparable on injectable manufacturing capabilities and regulated market supply, though much larger and more diversified.
  • Dr. Reddy's Laboratories: Indian pharmaceutical manufacturer with a sterile injectables portfolio and US FDA-approved facilities. Comparable on injectable manufacturing and US market access, though diversified across multiple dosage forms and therapy areas.
  • Cipla: Major Indian pharma company with sterile injectable and ophthalmic manufacturing capabilities. Comparable product overlap (injectables + ophthalmics) and similar India-based regulated market footprint, though at far larger scale.
  • Aurobindo Pharma: Large Indian generic and injectable manufacturer with US FDA-approved sterile facilities serving regulated markets. Overlaps with Wintac on injectable manufacturing and US supply, but operates at materially greater scale and breadth.

Others

  • Alcon: Global leader in ophthalmic pharmaceuticals and a stated customer of Wintac. Included as an adjacent ecosystem participant — both a customer and a benchmark for the ophthalmic capabilities Wintac has built.

Direct peers

  • Strides Pharma Science: Indian pharma company with a focused sterile injectables (including ophthalmics) portfolio supplying the US market. Direct comparable on injectable focus, India manufacturing base, and US FDA-regulated supply model.
  • Gland Pharma: India-based sterile injectable manufacturer and CDMO with US FDA-approved facilities supplying global pharma companies. Direct comparable on geography, manufacturing footprint, injectable focus, and customer profile.

Market position

Strengths4 records

Weaknesses4 records

Key risks6 records

Key highlights6 records

Customer concentration

Wintac Ltd. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wintac Ltd. leadership team

Management profile

Number of profiles

Profiles1 record

Wintac Ltd. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wintac Ltd. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wintac Ltd.

What does Wintac Ltd. do?

Wintac Ltd. operates an FDA-inspected sterile manufacturing facility focused on contract manufacturing of sterile injectable and ophthalmic pharmaceutical products. The company provides formulation, development, and commercial-scale production services for global pharmaceutical clients, leveraging cGMP-compliant operations and regulatory expertise.

Is Wintac Ltd. a public or private company?

Wintac Ltd. is a public company. It is classified as public and is currently operating.

When was Wintac Ltd. founded?

Wintac Ltd. was founded in 1987. It employs 101 to 250 people.

Where is Wintac Ltd. based?

Wintac Ltd. is headquartered in Bengaluru, India, in the Asia region.

Who are Wintac Ltd.'s main competitors?

Regional players on record are Ajanta Pharma and Hikal Ltd.. Broad incumbents are Lupin, Dr. Reddy's Laboratories, Cipla and Aurobindo Pharma. Alcon is listed as an others. Direct peers are Strides Pharma Science and Gland Pharma.

Does Wintac Ltd. have an API?

No public API is recorded for Wintac Ltd..

What industry is Wintac Ltd. in?

Wintac Ltd.'s product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services, with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NDTV ProfitWintac Ltd Share Price, Stock PriceWintac Ltd's share price was ₹0.00 as of 20 May 2026, with no trading activity. The stock opened and closed at ₹0.00, and its market capitalization was ₹0. The 52-week range was also ₹0.00 to ₹0.00.PR NewswireEndo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac LimitedEndo International plc announced the termination of acquisition agreements by its subsidiaries to acquire Somerset Therapeutics, LLC and the business of its India-based affiliate Wintac Limited. The termination, effective February 27, 2019, was triggered by prolonged regulatory approval processes in India, with no clarity on when approvals would be received and no penalties associated with the termination. The company stated it remains focused on enhancing the value of its existing businesses following the breakdown of the transaction that was initially executed in April 2018.PR NewswireEndo to Acquire Somerset Therapeutics and Business of Affiliate Wintac LimitedEndo International plc announced definitive agreements to acquire Somerset Therapeutics and the business of its affiliate Wintac Limited for approximately $190 million. The transaction aims to expand Endo's Par Sterile injectable business by securing commercial products, a robust pipeline, and manufacturing capabilities from the New Jersey-based pharmaceutical company and its India-based partner. Expected to close by the end of 2018 subject to regulatory approvals, the deal integrates Somerset's portfolio and Wintac's Bangalore facility into Endo's operations.